We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$247M
AUM Growth
+$13M
Cap. Flow
+$10.3M
Cap. Flow %
4.16%
Top 10 Hldgs %
29.07%
Holding
579
New
47
Increased
103
Reduced
79
Closed
37

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.64%
2 Healthcare 10.63%
3 Financials 10.49%
4 Technology 10.24%
5 Consumer Discretionary 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
26
Skyworks Solutions
SWKS
$11.1B
$3.26M 1.32%
33,707
-36
-0.1% -$3.5K
GD icon
27
General Dynamics
GD
$97.2B
$3.21M 1.3%
17,193
+586
+4% +$120K
KLAC icon
28
KLA
KLAC
$242B
$3.17M 1.28%
308,640
+120
+0% +$1.3K
FLG
29
Flagstar Bank National Association
FLG
$5.61B
$3.15M 1.28%
95,223
+9,235
+11% +$332K
AVGO icon
30
Broadcom
AVGO
$1.7T
$3.14M 1.27%
129,480
-1,320
-1% -$32.4K
ZBRA icon
31
Zebra Technologies
ZBRA
$17.2B
$3.14M 1.27%
+21,906
New +$3.23M
WAL icon
32
Western Alliance Bancorporation
WAL
$8.83B
$3.09M 1.25%
54,566
+1,609
+3% +$96.5K
WM icon
33
Waste Management
WM
$87.5B
$3.09M 1.25%
37,938
+621
+2% +$51.4K
ON icon
34
ON Semiconductor
ON
$29B
$3.06M 1.24%
+137,634
New +$3.33M
TSN icon
35
Tyson Foods
TSN
$18.1B
$2.97M 1.2%
43,136
+870
+2% +$60.5K
CE icon
36
Celanese
CE
$4.9B
$2.96M 1.2%
26,652
+317
+1% +$35K
EMN icon
37
Eastman Chemical
EMN
$8.14B
$2.83M 1.15%
28,347
+153
+0.5% +$16.2K
TMUS icon
38
T-Mobile US
TMUS
$195B
$2.76M 1.12%
46,251
+2,294
+5% +$136K
TIP icon
39
iShares TIPS Bond ETF
TIP
$15B
$2.63M 1.07%
23,315
+501
+2% +$56.2K
USB icon
40
US Bancorp
USB
$98.7B
$2.35M 0.95%
46,948
-974
-2% -$49.4K
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$2.34M 0.95%
8,615
+25
+0.3% +$6.75K
WCG
42
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.05M 0.83%
+8,328
New +$1.81M
CVS icon
43
CVS Health
CVS
$124B
$1.94M 0.79%
30,143
+30,111
+94,097% +$1.98M
IBDL
44
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$1.62M 0.65%
64,584
-4,062
-6% -$102K
MINT icon
45
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.4B
$1.54M 0.62%
15,149
-159
-1% -$16.1K
IBDO
46
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$1.5M 0.61%
61,805
+56,405
+1,045% +$1.37M
ENTA icon
47
Enanta Pharmaceuticals
ENTA
$410M
$1.29M 0.52%
11,115
-3,600
-24% -$359K
FRA icon
48
BlackRock Floating Rate Income Strategies Fund
FRA
$386M
$1.15M 0.46%
82,500
+36,300
+79% +$519K
BFYT
49
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$1.09M 0.44%
33,600
+20,300
+153% +$619K
CPS icon
50
Cooper-Standard Automotive
CPS
$483M
$1.07M 0.43%
8,219

Similar funds

AlphaMark Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, AlphaMark Advisors held 579 positions worth $247M, up 5.6% from $234M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

AlphaMark Advisors deployed $10.3M of net new capital in Q2 2018, opening 47 new positions and adding to 103 existing holdings. Its largest new stake was ON Semiconductor: 137,634 shares worth $3.06M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBonds Dec 2018 Term Corporate ETF, an estimated $5.03M trimmed.

  • AlphaMark Advisors's largest Q2 2018 buy was ON Semiconductor: 137,634 shares worth $3.06M.
  • AlphaMark Advisors added most to iShares iBonds Dec 2022 Term Corporate ETF in Q2 2018, an estimated $5.92M increase.
  • AlphaMark Advisors's biggest Q2 2018 reduction was iShares iBonds Dec 2018 Term Corporate ETF, cutting an estimated $5.03M.
  • AlphaMark Advisors fully exited Credit Acceptance in Q2 2018, selling an estimated $989K.
  • AlphaMark Advisors's ten largest holdings make up 29% of its $247M portfolio in Q2 2018.
  • AlphaMark Advisors opened 47 new positions and closed 37 in Q2 2018.
  • AlphaMark Advisors's portfolio value rose 5.6% quarter-over-quarter to $247M.

Based on AlphaMark Advisors's 13F filing for Q2 2018, filed 3 Aug 2018.